Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 287

Results For "RAT"

8031 News Found

Mankind Pharma completes acquisition of BSV
News | October 25, 2024

Mankind Pharma completes acquisition of BSV

Potential to optimize and build on the synergies in commercial operations, distribution, manufacturing, supply chain etc.


European Food Safety Authority confirms safety of silica as food additive
News | October 23, 2024

European Food Safety Authority confirms safety of silica as food additive

Silica is a proven and highly effective anti-caking agent that has been used for decades


Zydus receives acceptability from WHO for Typhoid Vi Conjugate Vaccine ZyVac TCV
Drug Approval | October 23, 2024

Zydus receives acceptability from WHO for Typhoid Vi Conjugate Vaccine ZyVac TCV

Company receives acceptability, in principle, for ZyVac TCV making it eligible for purchase by United Nations procurement agencies


Aptar bags contract to advance novel sterilization technology for medical devices
Medical Device | October 23, 2024

Aptar bags contract to advance novel sterilization technology for medical devices

ActivShield technology is a portable, novel sterilization modality that does not require conventional infrastructure


Mastek partners Innovaccer to transform value-based care and improve patient experience
Digitisation | October 22, 2024

Mastek partners Innovaccer to transform value-based care and improve patient experience

This partnership will enable healthcare organizations to provide best-in-class patient/consumer experiences


Senores Pharmaceuticals gets SEBI nod for IPO
News | October 21, 2024

Senores Pharmaceuticals gets SEBI nod for IPO

The proceeds from its fresh issuance to the extent of Rs 107 crore will be utilized for funding the capital expenditure requirements


Sunbird Bio raises additional US $14 million to advance Alzheimer blood tech test
News | October 21, 2024

Sunbird Bio raises additional US $14 million to advance Alzheimer blood tech test

Financing includes new funding from leading global organizations Eli Lilly and Company and EDBI


JB Pharma outlines key ESG goals & targets in Third Sustainability Report FY24
Sustainability | October 21, 2024

JB Pharma outlines key ESG goals & targets in Third Sustainability Report FY24

JB’s absolute Scope1 & Scope2 emissions reduced by 13.9 % in the last financial year, despite turnover increasing by 11%